<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1401">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142917</url>
  </required_header>
  <id_info>
    <org_study_id>2021-10-092-001</org_study_id>
    <nct_id>NCT05142917</nct_id>
  </id_info>
  <brief_title>The Effect of tDCS Based on Functional Brain Imaging for Subacute Stroke Patients</brief_title>
  <official_title>The Effect of tDCS Based on Functional Brain Imaging for Subacute Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether brain imaging-based hand function area&#xD;
      tDCS stimulation is more effective than conventional stimulation or sham stimulation for&#xD;
      improving hand motor function.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of score: Fugl-Meyer Assessment</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>The score is a stroke-specific, performance-based impairment index. The degree of impairment of upper and lower limbs is measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes of score: 9-hole pegboard test</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>The test is a standardized, quantitative assessment used to measure finger dexterity of a patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of score: Grip &amp; Tip pinch strength test</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>The test is to measure the maximum isometric strength of hand, forearm, and finger muscles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Box &amp; Block test</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>The test is used to measure the gross manual dexterity of a patient, or of a person using an upper limb prosthetic device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of score: Jebsen-Taylor hand function test</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>This test is a standardized and objective measure of fine and gross motor hand function using simulated activities of daily living (ADL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of score: Korean-Montreal Cognitive Assessment</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>This test is a cognitive function test tool consisting of spatiotemporal/executive function, naming, memory, attention, language function, abstraction, and orientation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of score: Korean version of Modified Barthel Index</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>Measure of physical disability used widely to assess behaviour relating to activities of daily living for stroke patients or patients with other disabling conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of score: Geriatric Depression Scale-Short Form</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>The test is a self-report measure of depression in older adults.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cortical activity using fNIRS signals</measure>
    <time_frame>Baseline, within 48 hours after #1-10 brain stimulation sessions (5 times per week, total 2 week schedule), 1 month after ten brain stimulation session</time_frame>
    <description>Cortical activities before, during and after brain stimulation sessions are compared.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Resting-state functional MRI</measure>
    <time_frame>Baseline (Before stimulation sessions)</time_frame>
    <description>Before intervention, MRI is acquired to extract brain characteristics of stroke patients.</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in cortical activity using fNIRS signals</measure>
    <time_frame>Baseline (Before stimulation sessions)</time_frame>
    <description>Before intervention, fNIRS image is acquired to extract cortical activation of stroke patients.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>fNIRS based hand motor area real stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Real stimulation is applied to functional brain image-based hand function area (20 minutes) and then hand motor task (18 minutes).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional hand motor area real stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Real stimulation is applied to the traditional hand function area (20 minutes) and then hand motor task (18 minutes).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional hand motor area sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation is applied to the traditional hand function area (20 minutes) and then hand motor task (18 minutes).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation</intervention_name>
    <description>Transcranial direct current stimulation is a form of noninvasive neuromodulation that uses constant and low direct current delivered via electrodes on the scalp.</description>
    <arm_group_label>Traditional hand motor area real stimulation</arm_group_label>
    <arm_group_label>fNIRS based hand motor area real stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hand motor task</intervention_name>
    <description>Various type of hand motor tasks are applied to stroke patients.</description>
    <arm_group_label>Traditional hand motor area real stimulation</arm_group_label>
    <arm_group_label>Traditional hand motor area sham stimulation</arm_group_label>
    <arm_group_label>fNIRS based hand motor area real stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Unilateral stroke patients aged 19 to 80 years&#xD;
&#xD;
          -  Patients with subacute stroke within 4 weeks of onset&#xD;
&#xD;
          -  Patients with moderate or severe upper extremity dysfunction with an upper extremity&#xD;
             FMA score of less than 58 in motor function evaluation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Accompanied by an existing serious neurogenic disease&#xD;
&#xD;
          -  Existing significant psychiatric disorders such as major schizophrenia, bipolar&#xD;
             disorder, and dementia.&#xD;
&#xD;
          -  If there are difficulties in conducting the research&#xD;
&#xD;
          -  Any patients who are judged by the investigator to be difficult to participate in this&#xD;
             study&#xD;
&#xD;
          -  Exclusion criteria for transcranial direct current stimulation:&#xD;
&#xD;
             i) Patients with implanted medical devices in the body (e.g. pacemakers) ii) When a&#xD;
             metal object is inserted in the skull iii) If there is a wound on the skin of the&#xD;
             attachment site iv) history of epilepsy v) Pregnant and lactating women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Yun-Hee Kim, MD, PhD</last_name>
      <phone>82-2-3410-2824</phone>
      <email>yunkim@skku.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 28, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

